勒梅特微管医疗 LMAT 深 沪
等待开盘 05-20 09:30:00 美东时间
101.24
+0.410
+0.41%
华盛通- 最 高102.48
- 今 开100.53
- 成交量 9.15万股
- 最 低 99.415
- 昨 收 100.83
- 总市值 23.13亿
- 52周最高 118.01
- 市盈率 静 40.21
- 换手率 0.40%
- 52周最低 78.355
- 委 比 75.44%
- 总股本 2285.07万
- 历史最高 118.01
- 量 比 0.27
- 振 幅 3.04%
- 历史最低 -0.055
- 每 手 1
- 风险率 10.61%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 绩后暴跌10%，ARM仍获高盛、富国银行等多家大行上调目标价；康宁、优步、飞塔信息、西维斯、Agilon Health等获多家大行上调目标价
今日重点评级关注：Citizens：维持BioCryst制药"跑赢大市"评级，目标价从25美元升至28美元；富国银行：维持曼恩凯德生物医疗"超配"评级，目标价从8美元升至10美元
05-08 12:05
LeMaitre to Present at the Bank of America Healthcare Conference
LeMaitre Vascular, Inc. announced that its management will present at the Bank of America Healthcare Conference on May 13, 2026, at 5:15 PM PT. The company specializes in devices, implants, and services for treating peripheral vascular disease, affecting over 200 million globally. Additional details are available at www.lemaitre.com.
05-07 21:15
美股大行评级 | 潜在涨幅20%！15家机构集体上调AMD目标价；Lumentum、神经分泌生物科学、伊顿公司、美国电力等获多家大行上调目标价
今日重点评级关注：Citizens：维持Avalo Therapeutics"跑赢大市"评级，目标价从52美元升至62美元；BTIG：维持Avalo Therapeutics"买入"评级，目标价从40美元升至58美元
05-07 12:37
Wells Fargo Maintains Equal-Weight on LeMaitre Vascular, Raises Price Target to $104
Wells Fargo analyst Nathan Treybeck maintains LeMaitre Vascular (NASDAQ:LMAT) with a Equal-Weight and raises the price target from $94 to $104.
05-06 21:44
LeMaitre Vascular Reports Q1 2026 Results: Full Earnings Call Transcript
On Tuesday, LeMaitre Vascular (NASDAQ:LMAT) discussed first-quarter financial r...
05-06 06:10
LeMaitre Vascular Sees Q2 GAAP EPS $0.79-$0.84 vs $0.75 Est; Sees Sales $70.500M-$72.500M vs $71.105M Est
LeMaitre Vascular (NASDAQ:LMAT) is looking for Q2 GAAP EPS of $0.79-$0.84 vs $0.75 analyst estimate. sees sales of $70.500 million-$72.500 million vs $71.105 million analyst estimate.
05-06 04:08
Earnings Scheduled For May 5, 2026
Companies Reporting Before The Bell • Repligen (NASDAQ:RGEN) is projected to re...
05-05 19:12
LeMaitre Vascular announces annual shareholder meeting
LeMaitre Vascular announces annual shareholder meeting LeMaitre Vascular schedules annual shareholder meeting in Burlington, Massachusetts on June 2, 2026. Shareholders will vote on election of two Class II directors, including David B. Roberts and John A. Roush. Advisory vote set on 2025 named exec
04-14 19:35
LeMaitre Vascular Announces Board Changes and Size Reduction
An update from Lemaitre Vascular ( ($LMAT) ) is now available. On April 8, 2026...
04-14 19:19
LeMaitre Vascular director Bridget Ross to step down, not seek re-election
LeMaitre Vascular director Bridget Ross to step down, not seek re-election LeMaitre Vascular director Bridget Ross will not stand for re-election at June 2, 2026 annual meeting. Ross will remain on board until her term ends at conclusion of annual meeting. Board nominated David B. Roberts for electi
04-14 18:46
